Royal Bank of Canada’s NEVRO CORP. NVRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,999
| Closed | -$35K | – | 7499 |
|
|
2025
Q1 | $35K | Sell |
5,999
-280
| -4% | -$1.48K | ﹤0.01% | 5714 |
|
|
2024
Q4 | $23K | Buy |
6,279
+1,614
| +35% | +$7.45K | ﹤0.01% | 6066 |
|
|
2024
Q3 | $26K | Buy |
4,665
+312
| +7% | +$2.18K | ﹤0.01% | 6017 |
|
|
2024
Q2 | $36K | Buy |
4,353
+2,422
| +125% | +$25.8K | ﹤0.01% | 5810 |
|
|
2024
Q1 | $29K | Sell |
1,931
-10,988
| -85% | -$182K | ﹤0.01% | 5763 |
|
|
2023
Q4 | $279K | Buy |
12,919
+6,369
| +97% | +$114K | ﹤0.01% | 4799 |
|
|
2023
Q3 | $126K | Buy |
6,550
+657
| +11% | +$14K | ﹤0.01% | 5208 |
|
|
2023
Q2 | $149K | Buy |
5,893
+2,278
| +63% | +$65.8K | ﹤0.01% | 5009 |
|
|
2023
Q1 | $131K | Sell |
3,615
-2,450
| -40% | -$86K | ﹤0.01% | 4962 |
|
|
2022
Q4 | $240K | Buy |
6,065
+4,211
| +227% | +$175K | ﹤0.01% | 4724 |
|
|
2022
Q3 | $86K | Buy |
1,854
+168
| +10% | +$7.8K | ﹤0.01% | 5420 |
|
|
2022
Q2 | $75K | Sell |
1,686
-1,916
| -53% | -$105K | ﹤0.01% | 5519 |
|
|
2022
Q1 | $260K | Sell |
3,602
-5,073
| -58% | -$366K | ﹤0.01% | 4856 |
|
|
2021
Q4 | $703K | Buy |
8,675
+3,235
| +59% | +$324K | ﹤0.01% | 4175 |
|
|
2021
Q3 | $633K | Sell |
5,440
-16,657
| -75% | -$2.18M | ﹤0.01% | 4153 |
|
|
2021
Q2 | $3.66M | Buy |
22,097
+1,333
| +6% | +$208K | ﹤0.01% | 2529 |
|
|
2021
Q1 | $2.9M | Buy |
20,764
+2,264
| +12% | +$369K | ﹤0.01% | 2709 |
|
|
2020
Q4 | $3.2M | Buy |
18,500
+2,641
| +17% | +$428K | ﹤0.01% | 2513 |
|
|
2020
Q3 | $2.21M | Buy |
15,859
+644
| +4% | +$86K | ﹤0.01% | 2611 |
|
|
2020
Q2 | $1.82M | Buy |
15,215
+2,108
| +16% | +$250K | ﹤0.01% | 2697 |
|
|
2020
Q1 | $1.31M | Buy |
13,107
+769
| +6% | +$92.5K | ﹤0.01% | 2824 |
|
|
2019
Q4 | $1.45M | Buy |
12,338
+2,513
| +26% | +$249K | ﹤0.01% | 3147 |
|
|
2019
Q3 | $844K | Buy |
9,825
+9,423
| +2,344% | +$713K | ﹤0.01% | 3480 |
|
|
2019
Q2 | $26K | Buy |
402
+40
| +11% | +$2.49K | ﹤0.01% | 5584 |
|
|
2019
Q1 | $23K | Sell |
362
-729
| -67% | -$34.3K | ﹤0.01% | 5600 |
|
|
2018
Q4 | $42K | Sell |
1,091
-7,478
| -87% | -$332K | ﹤0.01% | 5196 |
|
|
2018
Q3 | $488K | Buy |
8,569
+1,959
| +30% | +$122K | ﹤0.01% | 3915 |
|
|
2018
Q2 | $528K | Sell |
6,610
-1,092
| -14% | -$90.6K | ﹤0.01% | 3740 |
|
|
2018
Q1 | $666K | Buy |
7,702
+3,035
| +65% | +$245K | ﹤0.01% | 3493 |
|
|
2017
Q4 | $322K | Sell |
4,667
-141,725
| -97% | -$11.3M | ﹤0.01% | 4123 |
|
|
2017
Q3 | $13.3M | Sell |
146,392
-82,295
| -36% | -$7.05M | 0.01% | 1349 |
|
|
2017
Q2 | $17M | Buy |
228,687
+24,101
| +12% | +$1.93M | 0.01% | 1157 |
|
|
2017
Q1 | $19.2M | Sell |
204,586
-109,088
| -35% | -$9.88M | 0.01% | 1059 |
|
|
2016
Q4 | $22.8M | Buy |
313,674
+101,295
| +48% | +$8.67M | 0.01% | 979 |
|
|
2016
Q3 | $22.2M | Sell |
212,379
-75,176
| -26% | -$6.79M | 0.01% | 946 |
|
|
2016
Q2 | $21.2M | Buy |
287,555
+38,309
| +15% | +$2.6M | 0.01% | 920 |
|
|
2016
Q1 | $14M | Buy |
249,246
+249,226
| +1,246,130% | +$14.7M | 0.01% | 1164 |
|
|
2015
Q4 | $1K | Sell |
20
-740
| -97% | -$39.6K | ﹤0.01% | 6504 |
|
|
2015
Q3 | $35K | Sell |
760
-73
| -9% | -$3.54K | ﹤0.01% | 5318 |
|
|
2015
Q2 | $45K | Buy |
+833
| New | +$42.4K | ﹤0.01% | 5277 |
|
|
2015
Q1 | – | Sell |
-68
| Closed | -$3K | – | 6449 |
|
|
2014
Q4 | $3K | Buy |
+68
| New | +$2.14K | ﹤0.01% | 5920 |
|
Other funds holding NVRO
Royal Bank of Canada's NVRO Position: Q2 2025 in Review
Royal Bank of Canada sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 5,999 shares — an estimated $35K sold.
Royal Bank of Canada first reported a position in NVRO in Q4 2014 and held it in 41 quarters. The position peaked at $22.8M in Q4 2016. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.
- Royal Bank of Canada reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
- Royal Bank of Canada sold 5,999 NEVRO CORP. shares in Q2 2025, an estimated $35K.
- Royal Bank of Canada first reported a position in NEVRO CORP. in Q4 2014 and held it in 41 quarters.
- Royal Bank of Canada's NEVRO CORP. position peaked at $22.8M in Q4 2016.
- 1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.
Based on Royal Bank of Canada's 13F filing for Q2 2025, filed 14 Aug 2025.